4.2 Review

Core Myopathies

Journal

SEMINARS IN PEDIATRIC NEUROLOGY
Volume 18, Issue 4, Pages 239-249

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.spen.2011.10.005

Keywords

-

Funding

  1. Guy's and St Thomas' Charitable Foundation [070404]
  2. National Commissioning Group (NCG) of the UK
  3. Guy's Hospital

Ask authors/readers for more resources

The core myopathies, Central Core Disease and Multiminicore Disease, are heterogeneous congenital myopathies with the common defining histopathological feature of focally reduced oxidative enzyme activity (central cores, multiminicores). Mutations in the gene encoding for the skeletal muscle ryanodine (RyR1) receptor are the most common cause. Mutations in the selenoprotein N (SEPN1) gene cause a less common variant. Pathogenic mechanisms underlying dominant RYR1 mutations have been extensively characterized, whereas those associated with recessive RYR1 and SEPN1 mutations are emerging. Identifying a specific genetic defect from the histopathological diagnosis of a core myopathy is complex and ought to be informed by a combined appraisal of histopathological, clinical, and, increasingly, muscle magnetic resonance imaging data. The present review aims at giving an overview of the main genetic and clinicopathological findings, with a major emphasis on features likely to inform the diagnostic process, as well as current treatments and perspectives for future research. Semin Pediatr Neurol 18:239-249 (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Anesthesiology

Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing

Luuk R. van den Bersselaar, Anna Hellblom, Mejdan Gashi, Erik-Jan Kamsteeg, Nicol C. Voermans, Heinz Jungbluth, Joris de Puydt, Luc Heytens, Sheila Riazi, Marc M. J. Snoeck

Summary: The introduction of next-generation sequencing has led to an increase in the identification of RYR1 variants in the diagnosis of neuromuscular disorders. This study examines the referral indications and outcomes of patients without a personal/family history of adverse anesthetic events to malignant hyperthermia units. It is found that the proportion of patients without such history has increased, and those with a personal/family history are more likely to be diagnosed as malignant hyperthermia-susceptible.

ANESTHESIOLOGY (2022)

Review Anesthesiology

Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders-a scoping review

Luuk R. van den Bersselaar, Madelief Gubbels, Sheila Riazi, Luc Heytens, Heinz Jungbluth, Nicol C. Voermans, Marc M. J. Snoeck

Summary: This scoping review examined the anesthetic management and perioperative complications of patients with neuromuscular disorders (NMDs). The included studies mainly consisted of small retrospective studies and case reports, providing limited evidence. Preanesthetic neuromuscular monitoring can be useful for precise dosing of neuromuscular blocking agents in myasthenia gravis patients. Sugammadex is associated with fewer postoperative myasthenic crises. The choice of anesthetic agents and their association with perioperative complications in NMD patients require further investigation.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2022)

Article Clinical Neurology

European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders

Luuk R. van den Bersselaar, Luc Heytens, Helga C. A. Silva, Jens Reimann, Giorgio Tasca, Oscar Diaz-Cambronero, Nicoline Lokken, Anna Hellblom, Philip M. Hopkins, Henrik Rueffert, Boerge Bastian, Juan Jesus Vilchez, Robyn Gillies, Stephan Johannsen, Francis Veyckemans, Tino Muenster, Andrea Klein, Ron Litman, Heinz Jungbluth, Sheila Riazi, Nicol C. Voermans, Marc M. J. Snoeck

Summary: The European Neuromuscular Centre (ENMC) has released a consensus statement on anaesthesia in patients with neuromuscular disorders. Based on literature research and expert opinions, specific recommendations have been formulated for different types of myopathies and neuromuscular junction disorders. General recommendations for anaesthetic management of patients with neuromuscular disorders are also provided in this consensus statement.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH)

Sheila Riazi, Luuk R. van den Bersselaar, Gunilla Islander, Luc Heytens, Marc M. J. Snoeck, Andrew Bjorksten, Robyn Gillies, George Dranitsaris, Anna Hellblom, Susan Treves, Gudrun Kunst, Nicol C. Voermans, Heinz Jungbluth

Summary: This study investigated the role of pre-operative exercise and pyrexia in malignant hyperthermia. The findings suggest a link between pre-operative exercise, pyrexia, and malignant hyperthermia.

NEUROMUSCULAR DISORDERS (2022)

Article Anesthesiology

Oral Dantrolene for Myopathic Symptoms in Malignant Hyperthermia-Susceptible Patients: A 25-Year Retrospective Cohort Study of Adverse Effects and Tolerability

Carlos A. Ibarra Moreno, Natalia Kraeva, Elena Zvaritch, Heinz Jungbluth, Nicol C. Voermans, Sheila Riazi

Summary: In this retrospective study, oral dantrolene was found to relieve myopathic symptoms in patients susceptible to malignant hyperthermia. The treatment was well tolerated with no serious adverse effects reported, and the majority of patients experienced symptom improvement. These findings provide a basis for further clinical trials to evaluate the efficacy of oral dantrolene in MH-related myopathies.

ANESTHESIA AND ANALGESIA (2023)

Review Pediatrics

New treatments in spinal muscular atrophy

Vasantha Lakshmi Gowda, Miguel A. Fernandez-Garcia, Heinz Jungbluth, Elizabeth Wraige

Summary: Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by gene mutations. Clinical trials have shown that several compounds can restore survival motor neuron (SMN) protein production in SMA patients, thus altering the natural course of the disease. Currently, three drugs have been authorized for SMA treatment. However, clinicians face challenges in using these drugs, and early diagnosis at the pre-symptomatic stage is crucial.

ARCHIVES OF DISEASE IN CHILDHOOD (2023)

Editorial Material Clinical Neurology

Clinical Reasoning: A Teenage Girl With Progressive Hyperkinetic Movements, Seizures, and Encephalopathy

Sonia Khamis, Maria R. Mitakidou, Michael Champion, Sushma Goyal, Rachel L. Jones, Ata Siddiqui, Saraswathy Sabanathan, Tammy Hedderly, Jean-Pierre Lin, Heinz Jungbluth, Apostolos Papandreou

Summary: The epilepsy-dyskinesia spectrum is being recognized more often in neurogenetic and neurometabolic conditions, but diagnosing it can be challenging due to its clinical and genetic heterogeneity, atypical presentations, rareness, and the lack of biomarkers. This report describes a case of a teenage girl with a complex neurologic presentation, highlighting the importance of clinical awareness, timely diagnosis, and the utility of next-generation sequencing in determining the underlying etiology.

NEUROLOGY (2023)

Article Clinical Neurology

The Spectrum of MORC2-Related Disorders: A Potential Link to Cockayne Syndrome

Seth A. Stafki, Johnnie Turner, Hannah R. Littel, Christine C. Bruels, Don Truong, Ursula Knirsch, Georg M. Stettner, Urs Graf, Wolfgang Berger, Maria Kinali, Heinz Jungbluth, Christina A. Pacak, Jayne Hughes, Amytice Mirchi, Alexa Derksen, Catherine Vincent-Delorme, Arjan F. Theil, Genevieve Bernard, David Ellis, Hiva Fassihi, Alan R. Lehmann, Vincent Laugel, Shehla Mohammed, Peter B. Kang

Summary: Research has found that pathogenic variants in the MORC2 gene are associated with phenotypic similarities to Cockayne syndrome (CS) and accelerated aging features. Unlike traditional DNA repair disorders, MORC2-related disorders are not associated with a defect in transcription-coupled nucleotide excision repair and follow a dominant pattern of inheritance, with variants typically arising de novo. The results suggest that MORC2 should be included in diagnostic genetic test panels for evaluating microcephaly and/or suspected DNA repair disorders.

PEDIATRIC NEUROLOGY (2023)

Review Clinical Neurology

Muscle cramps and contractures: causes and treatment

Jildou N. Dijkstra, Eline Boon, Nick Kruijt, Esther Brusse, Sithara Ramdas, Heinz Jungbluth, Baziel G. M. van Engelen, Jon Walters, Nicol C. Voermans

Summary: Muscle cramps are painful, involuntary contractions that are typically a normal part of human physiology. They can be caused by various acquired or inherited factors, but rarely by progressive systemic or neuromuscular diseases. General practitioners and neurologists often encounter patients with muscle cramps and less frequently those with contractures. Clinicians need to determine whether it is a muscle cramp, contracture, or mimic, as well as the cause and appropriate diagnostic and treatment strategies.

PRACTICAL NEUROLOGY (2023)

Article Pediatrics

Successful heart transplant in a child with congenital core myopathy and delayed-onset restrictive cardiomyopathy due to recessive mutations in the titin (TTN) gene

Julie Wacker, Stefano Di Bernardo, Johannes Alexander Lobrinus, Heinz Jungbluth, Mathias Gautel, Maurice Beghetti, Joel Fluss

Summary: This case report presents a boy with congenital core myopathy caused by compound heterozygosity for TTN variants. The boy developed rapidly evolving restrictive cardiomyopathy in infancy and underwent heart transplantation at the age of 5, with favorable long-term cardiac and neuromuscular outcomes.

PEDIATRIC TRANSPLANTATION (2023)

Article Clinical Neurology

Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility

Luuk R. van den Bersselaar, Nens van Alfen, Nick Kruijt, Erik-Jan Kamsteeg, Miguel A. Fernandez-Garcia, Susan Treves, Sheila Riazi, Chu-Ya Yang, Ignacio Malagon, Lucas T. van Eijk, Baziel G. M. van Engelen, Gert-Jan Scheffer, Heinz Jungbluth, Marc M. J. Snoeck, Nicol C. Voermans

Summary: A muscle ultrasound study on 40 patients with RYR1 variants associated with MH susceptibility revealed that 38% had abnormal ultrasound results, 10% had borderline results, and 53% had normal results. Muscle hypertrophy and increased echogenicity were common abnormalities observed.

JOURNAL OF NEUROMUSCULAR DISEASES (2023)

Article Pediatrics

Gene therapy for spinal muscular atrophy

Vasantha Lakshmi Gowda, Heinz Jungbluth, Elizabeth Wraige

ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2023)

Article Clinical Neurology

Respiratory features of centronuclear myopathy in the Netherlands

Sietse Bouma, Nicolle Cobben, Karlijn Bouman, Michael Gaytant, Ries van de Biggelaar, Jeroen van Doorn, Stacha F. I. Reumers, Nicoline B. M. Voet, Jonne Doorduin, Corrie E. Erasmus, Erik-Jan Kamsteeg, Heinz Jungbluth, Peter Wijkstra, Nicol C. Voermans

Summary: Centronuclear myopathy (CNM) is a group of muscle disorders characterized by muscle weakness and respiratory dysfunction caused by mutations in specific genes. This study collected respiratory function data from Dutch CNM patients and found that 54% of patients had respiratory dysfunction. The study provides a basis for future natural history studies.

NEUROMUSCULAR DISORDERS (2023)

Article Clinical Neurology

Pancreatitis in RYR1-related disorders

Dennis T. Famili, Arti Mistry, Oleg Gerasimenko, Julia Gerasimenko, Rachel M. Tribe, Eirini Kyrana, Anil Dhawan, Michael F. Goldberg, Nicol Voermans, Tracey Willis, Heinz Jungbluth

Summary: This study reports three patients with inherited neuromuscular disorders who also developed symptoms of acute pancreatitis. The findings suggest that patients with RYR1 gain-of-function variants may be at increased risk of developing acute pancreatitis.

NEUROMUSCULAR DISORDERS (2023)

Review Sport Sciences

Exertional Heat Stroke and Rhabdomyolysis: A Medical Record Review and Patient Perspective on Management and Long-Term Symptoms

Nick Kruijt, L. R. van den Bersselaar, M. T. E. Hopman, M. M. J. Snoeck, M. van Rijswick, T. G. H. Wiggers, H. Jungbluth, C. C. W. G. Bongers, N. C. Voermans

Summary: This study reveals major inconsistencies in prehospital and in-hospital management, highlighting the need for standardized protocols. A significant proportion of patients experience symptoms even 12 months after the event, including muscle and mental health issues; patients express a preference for more consistent advice when resuming activities and sports.

SPORTS MEDICINE-OPEN (2023)

No Data Available